Thioredoxin-like reductase Rv2466c

UniProtKB accession: O53193

Grouped By: Matching UniProtKB accession

Group Content:

Go to UniProtKB: O53193

UniProtKB description: In vitro, the reduced form of Rv2466c catalyzes the reduction and activation of TP053, which is a thienopyrimidine derivative drug that can kill both replicating and non-replicating M.tuberculosis.

Group Members:

Release Date:

Structure Features

Sequence Features

Experimental Features

Organisms

Protein Domains

Function

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

Thioredoxin-like reductase Rv2466c